SOD1 and amyotrophic lateral sclerosis: We tested the hypothesis that human iPSCs expressing a heterozygous SOD1-G93A mutation generated by CRISPR/Cas9 genome editing and their differentiation into MNs could be used as a faithful cell system that develops autonomous ALS-relevant pathological phenotypes.